Terms: = Breast cancer AND SOX2, MGC2413, 6657, ENSG00000181449, MCOPS3, P48431, ANOP3 AND Clinical Outcome
12 results:
1. Withaferin A mediated changes of miRNA expression in breast cancer-derived mammospheres.
Prajapati KS; Shuaib M; Gupta S; Kumar S
Mol Carcinog; 2022 Sep; 61(9):876-889. PubMed ID: 35770722
[TBL] [Abstract] [Full Text] [Related]
2. 3-O-(E)-p-Coumaroyl betulinic acid possess anticancer activity and inhibit Notch signaling pathway in breast cancer cells and mammosphere.
Kushwaha PP; Singh AK; Shuaib M; Prajapati KS; Vardhan PS; Gupta S; Kumar S
Chem Biol Interact; 2020 Sep; 328():109200. PubMed ID: 32702347
[TBL] [Abstract] [Full Text] [Related]
3. Chemotherapy-induced S100A10 recruits KDM6A to facilitate OCT4-mediated breast cancer stemness.
Lu H; Xie Y; Tran L; Lan J; Yang Y; Murugan NL; Wang R; Wang YJ; Semenza GL
J Clin Invest; 2020 Sep; 130(9):4607-4623. PubMed ID: 32427586
[TBL] [Abstract] [Full Text] [Related]
4. The Effect of a Newly Synthesized Ferrocene Derivative against MCF-7 breast cancer Cells and Spheroid Stem Cells through ROS Production and Inhibition of JAK2/STAT3 Signaling Pathway.
Nourbakhsh M; Farzaneh S; Taghikhani A; Zarghi A; Noori S
Anticancer Agents Med Chem; 2020; 20(7):875-886. PubMed ID: 31893999
[TBL] [Abstract] [Full Text] [Related]
5. Increased Expression of Gankyrin and Stemness Factor Oct-4 are Associated with Unfavorable clinical outcomes and Poor Benefit of Tamoxifen in breast Carcinoma Patients.
Jahangiri R; Mosaffa F; EmamiRazavi A; Gharib M; Jamialahmadi K
Pathol Oncol Res; 2020 Jul; 26(3):1921-1934. PubMed ID: 31853860
[TBL] [Abstract] [Full Text] [Related]
6. Nanoparticle Delivery of miR-708 Mimetic Impairs breast cancer Metastasis.
Ramchandani D; Lee SK; Yomtoubian S; Han MS; Tung CH; Mittal V
Mol Cancer Ther; 2019 Mar; 18(3):579-591. PubMed ID: 30679387
[TBL] [Abstract] [Full Text] [Related]
7. SIX2 Mediates Late-Stage Metastasis via Direct Regulation of
Oliphant MUJ; Vincent MY; Galbraith MD; Pandey A; Zaberezhnyy V; Rudra P; Johnson KR; Costello JC; Ghosh D; DeGregori J; Espinosa JM; Ford HL
Cancer Res; 2019 Feb; 79(4):720-734. PubMed ID: 30606720
[TBL] [Abstract] [Full Text] [Related]
8. Oct4 suppresses IR‑induced premature senescence in breast cancer cells through STAT3- and NF‑κB-mediated IL‑24 production.
Kim JY; Kim JC; Lee JY; Park MJ
Int J Oncol; 2018 Jul; 53(1):47-58. PubMed ID: 29749438
[TBL] [Abstract] [Full Text] [Related]
9. Expression of embryonal stem cell transcription factors in breast cancer: Oct4 as an indicator for poor clinical outcome and tamoxifen resistance.
Gwak JM; Kim M; Kim HJ; Jang MH; Park SY
Oncotarget; 2017 May; 8(22):36305-36318. PubMed ID: 28422735
[TBL] [Abstract] [Full Text] [Related]
10. A three-gene signature and clinical outcome in esophageal squamous cell carcinoma.
Sun LL; Wu JY; Wu ZY; Shen JH; Xu XE; Chen B; Wang SH; Li EM; Xu LY
Int J Cancer; 2015 Mar; 136(6):E569-77. PubMed ID: 25220908
[TBL] [Abstract] [Full Text] [Related]
11. A study of embryonic stem cell-related proteins in human astrocytomas: identification of Nanog as a predictor of survival.
Elsir T; Edqvist PH; Carlson J; Ribom D; Bergqvist M; Ekman S; Popova SN; Alafuzoff I; Ponten F; Nistér M; Smits A
Int J Cancer; 2014 Mar; 134(5):1123-31. PubMed ID: 24037901
[TBL] [Abstract] [Full Text] [Related]
12. An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors.
Ben-Porath I; Thomson MW; Carey VJ; Ge R; Bell GW; Regev A; Weinberg RA
Nat Genet; 2008 May; 40(5):499-507. PubMed ID: 18443585
[TBL] [Abstract] [Full Text] [Related]
